Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis

Young Sil Yoon, Dongryeol Ryu, Min Woo Lee, Sungpyo Hong, Seung-Hoi Koo

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

During fasting periods, hepatic glucose production is enhanced by glucagon to provide fuels for other organs. This process is mediated via cAMP-dependent induction of the CREB regulated transcriptional coactivator (CRTC) 2, a critical transcriptional activator for hepatic gluconeogenesis. We have previously shown that CRTC2 activity is regulated by AMP activated protein kinase (AMPK) family members. Here we show that adiponectin and thiazolidinedione directly regulate AMPK to modulate CRTC2 activity in hepatocytes. Adiponectin or thiazolidinedione lowered glucose production from primary hepatocytes. Treatment of both reagents reduced gluconeogenic gene expression as well as cAMP-mediated induction of CRE reporter, suggesting that these reagents directly affect CREB/CRTC2- dependent transcription. Furthermore, adiponectin or thiazolidinedione mediated repression of CRE activity is largely blunted by co-expression of phosphorylation defective mutant CRTC2, underscoring the importance of serine 171 residue of this factor. Taken together, we propose that adiponectin and thiazolidinedione promote the modulation of AMPK-dependent CRTC2 activity to influence hepatic gluconeogenesis.

Original languageEnglish
Pages (from-to)577-583
Number of pages7
JournalExperimental and Molecular Medicine
Volume41
Issue number8
DOIs
Publication statusPublished - 2009 Aug 31
Externally publishedYes

Fingerprint

Gluconeogenesis
Adiponectin
AMP-Activated Protein Kinases
Liver
Hepatocytes
Glucose
Phosphorylation
Transcription
Glucagon
Gene expression
Serine
Fasting
Modulation
Gene Expression
2,4-thiazolidinedione

Keywords

  • Adiponectin
  • AMP-activated protein kinases
  • CRTC2 protein, human
  • Gluconeogenesis
  • Liver
  • Thiazolidinediones

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry

Cite this

Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis. / Yoon, Young Sil; Ryu, Dongryeol; Lee, Min Woo; Hong, Sungpyo; Koo, Seung-Hoi.

In: Experimental and Molecular Medicine, Vol. 41, No. 8, 31.08.2009, p. 577-583.

Research output: Contribution to journalArticle

Yoon, Young Sil ; Ryu, Dongryeol ; Lee, Min Woo ; Hong, Sungpyo ; Koo, Seung-Hoi. / Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis. In: Experimental and Molecular Medicine. 2009 ; Vol. 41, No. 8. pp. 577-583.
@article{d91bad14e11046beab935646747ec67d,
title = "Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis",
abstract = "During fasting periods, hepatic glucose production is enhanced by glucagon to provide fuels for other organs. This process is mediated via cAMP-dependent induction of the CREB regulated transcriptional coactivator (CRTC) 2, a critical transcriptional activator for hepatic gluconeogenesis. We have previously shown that CRTC2 activity is regulated by AMP activated protein kinase (AMPK) family members. Here we show that adiponectin and thiazolidinedione directly regulate AMPK to modulate CRTC2 activity in hepatocytes. Adiponectin or thiazolidinedione lowered glucose production from primary hepatocytes. Treatment of both reagents reduced gluconeogenic gene expression as well as cAMP-mediated induction of CRE reporter, suggesting that these reagents directly affect CREB/CRTC2- dependent transcription. Furthermore, adiponectin or thiazolidinedione mediated repression of CRE activity is largely blunted by co-expression of phosphorylation defective mutant CRTC2, underscoring the importance of serine 171 residue of this factor. Taken together, we propose that adiponectin and thiazolidinedione promote the modulation of AMPK-dependent CRTC2 activity to influence hepatic gluconeogenesis.",
keywords = "Adiponectin, AMP-activated protein kinases, CRTC2 protein, human, Gluconeogenesis, Liver, Thiazolidinediones",
author = "Yoon, {Young Sil} and Dongryeol Ryu and Lee, {Min Woo} and Sungpyo Hong and Seung-Hoi Koo",
year = "2009",
month = "8",
day = "31",
doi = "10.3858/emm.2009.41.8.063",
language = "English",
volume = "41",
pages = "577--583",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "8",

}

TY - JOUR

T1 - Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis

AU - Yoon, Young Sil

AU - Ryu, Dongryeol

AU - Lee, Min Woo

AU - Hong, Sungpyo

AU - Koo, Seung-Hoi

PY - 2009/8/31

Y1 - 2009/8/31

N2 - During fasting periods, hepatic glucose production is enhanced by glucagon to provide fuels for other organs. This process is mediated via cAMP-dependent induction of the CREB regulated transcriptional coactivator (CRTC) 2, a critical transcriptional activator for hepatic gluconeogenesis. We have previously shown that CRTC2 activity is regulated by AMP activated protein kinase (AMPK) family members. Here we show that adiponectin and thiazolidinedione directly regulate AMPK to modulate CRTC2 activity in hepatocytes. Adiponectin or thiazolidinedione lowered glucose production from primary hepatocytes. Treatment of both reagents reduced gluconeogenic gene expression as well as cAMP-mediated induction of CRE reporter, suggesting that these reagents directly affect CREB/CRTC2- dependent transcription. Furthermore, adiponectin or thiazolidinedione mediated repression of CRE activity is largely blunted by co-expression of phosphorylation defective mutant CRTC2, underscoring the importance of serine 171 residue of this factor. Taken together, we propose that adiponectin and thiazolidinedione promote the modulation of AMPK-dependent CRTC2 activity to influence hepatic gluconeogenesis.

AB - During fasting periods, hepatic glucose production is enhanced by glucagon to provide fuels for other organs. This process is mediated via cAMP-dependent induction of the CREB regulated transcriptional coactivator (CRTC) 2, a critical transcriptional activator for hepatic gluconeogenesis. We have previously shown that CRTC2 activity is regulated by AMP activated protein kinase (AMPK) family members. Here we show that adiponectin and thiazolidinedione directly regulate AMPK to modulate CRTC2 activity in hepatocytes. Adiponectin or thiazolidinedione lowered glucose production from primary hepatocytes. Treatment of both reagents reduced gluconeogenic gene expression as well as cAMP-mediated induction of CRE reporter, suggesting that these reagents directly affect CREB/CRTC2- dependent transcription. Furthermore, adiponectin or thiazolidinedione mediated repression of CRE activity is largely blunted by co-expression of phosphorylation defective mutant CRTC2, underscoring the importance of serine 171 residue of this factor. Taken together, we propose that adiponectin and thiazolidinedione promote the modulation of AMPK-dependent CRTC2 activity to influence hepatic gluconeogenesis.

KW - Adiponectin

KW - AMP-activated protein kinases

KW - CRTC2 protein, human

KW - Gluconeogenesis

KW - Liver

KW - Thiazolidinediones

UR - http://www.scopus.com/inward/record.url?scp=70249127893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249127893&partnerID=8YFLogxK

U2 - 10.3858/emm.2009.41.8.063

DO - 10.3858/emm.2009.41.8.063

M3 - Article

VL - 41

SP - 577

EP - 583

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 8

ER -